Researchers in the Basque Health Service have published a study protocol for a clinical trial designed to evaluate whether a more intensive audit and feedback strategy can reduce low-value prescribing among older patients in primary care. The study, known as the AFFAP trial, will compare a standard audit and feedback approach with a version that includes facilitation by primary care pharmacists. The primary goal is to determine if this additional support can lower the proportion of patients aged 65 years or more who receive potentially inappropriate prescriptions for specific medication classes, including benzodiazepines, proton pump inhibitors, and opioids for non-cancer pain.
The trial will be conducted as a closed-cohort stepped-wedge cluster-randomised design across nine primary care centres within the Barakaldo-Sestao Integrated Health Organisation. This specific design allows all participating health centres to start under a control condition before sequentially crossing over to the intervention. Over a period of four months, the centres will operate under the standard audit and feedback protocol, which serves as a management tool to evaluate healthcare performance focusing on processes and outcomes. Following this initial control phase, one centre per step will be randomly assigned to the intervention at one-month intervals.
The intervention under investigation adds a specific component to the existing audit and feedback framework: primary care pharmacist-led facilitation. The study seeks to isolate the effect attributable to this facilitated audit and feedback strategy compared to the standard procedures involving audit and feedback reports. By comparing these two levels of intensity, the researchers hope to identify which characteristics of audit and feedback are most effective in changing clinical behaviour.
The study population will consist of at least 540 patients, with a minimum of 60 randomly selected patients from each of the nine participating centres. These patients will be aged 65 years or older and will be selected from the lists of general practitioners at the participating centres based on criteria for potentially inappropriate prescribing. Data collection will occur monthly throughout the study period, allowing researchers to track changes in prescribing patterns over time.
Statistical analysis will involve between-group comparisons of the proportion of patients in whom appropriateness of prescribing is achieved. The researchers plan to use generalised linear mixed models to account for the clustering of patients within centres and the effects of repeated measurements inherent in the stepped-wedge design. The analysis will aim to provide a robust estimate of the intervention’s impact on prescribing appropriateness.
In addition to the primary clinical outcomes, the trial will assess several implementation outcomes to understand how the intervention is received and executed. The study will also evaluate professionals’ adoption of the new strategies and their perceived feasibility.
The study is registered with ClinicalTrials.gov under the identifier NCT07336550, with registration occurring on 30 December 2025 and the last update on 11 May 2026. The protocol was published in BMC Primary Care on 30 October 2026. The research team includes authors from various institutions, including Alvaro Sanchez, Mikel Baza Bueno, and Alvaro Goñi, among others.
This trial addresses a significant challenge in primary care, which is the reduction of low-value prescribing in older adults. By testing a pharmacist-led facilitation model, the AFFAP trial aims to provide evidence on whether targeted support can effectively change prescribing habits. The results of this study will offer insights into the most effective components of audit and feedback strategies, potentially informing future quality improvement initiatives in primary care settings for older populations.
The findings discussed here are based on the planned methods and objectives outlined in the published protocol. The actual results of the trial, including any observed effects on prescribing rates, will be available only after the study is completed and the data are analysed.
Subject of Research: Protocol for a stepped-wedge cluster-randomised trial evaluating audit and feedback strategies to reduce low-value prescribing in primary care for patients aged 65 or more.
Article Title: AFFAP stepped-wedge cluster-randomised trial: study protocol for the comparative evaluation of audit and feedback-based de-implementation strategies to reduce low-value prescribing in primary care in patients aged 65 years or more
Article References: Sanchez, A., Baza Bueno, M., Vivanco, L., Perez, T., Martin, V., Bilbao, J., De La Rosa, L., Esteban, M., Santamarta, M. T., Sainz de Rozas, R., Lekue Alkorta, I., Rotaeche, R., Etxeberria, A., Millan, E., Parraza, N., Donaire, C., Vrotsou, K., Martinez Cobo, R., Merino-Inda, N., … Goñi, A. (2026). AFFAP stepped-wedge cluster-randomised trial: study protocol for the comparative evaluation of audit and feedback-based de-implementation strategies to reduce low-value prescribing in primary care in patients aged 65 years or more. BMC Primary Care. https://doi.org/10.1186/s12875-026-03602-0
Image Credits: AI Generated
DOI: 10.1186/s12875-026-03602-0
Keywords: primary care, audit and feedback, low-value prescribing, older adults, stepped-wedge trial, pharmacist facilitation, Basque Health Service, clinical trial protocol, AFFAP, stepped-wedge, cluster-randomised, trial
News Source: Ophelia Keating. (November 9, 2026). Trial Protocol Seeks to Cut Low-Value Prescribing in Older Adults. Scienmag.



